Effects of garlic extract on platelet aggregation: a randomized placebo-controlled double-blind study

Area of Science:

• Cardiovascular Research
• Nutritional Science
• Pharmacology

Background:

• Previous studies on garlic's effect on platelet aggregation yielded inconsistent results.
• Variations in study design and garlic preparations may explain discrepancies.
• Platelet aggregation plays a key role in thrombosis and cardiovascular events.

Purpose of the Study:

• To investigate the in vivo and in vitro effects of garlic extract on platelet aggregation.
• To assess the impact of garlic on serum thromboxane and lyso-platelet activating factor.
• To utilize a placebo-controlled, double-blind design for robust findings.

Main Methods:

• Healthy men were administered garlic extract or a placebo in a double-blind, placebo-controlled trial.
• Platelet aggregation was measured in response to adenosine diphosphate, platelet activating factor (PAF), and collagen.
• Serum thromboxane and lyso-platelet activating factor levels were analyzed.
• In vitro platelet aggregation assays were performed using varying concentrations of garlic extract.

Main Results:

• No significant differences in in vivo platelet aggregation were observed between the garlic and placebo groups.
• Serum thromboxane and lyso-platelet activating factor levels remained unchanged.
• In vitro, collagen-induced platelet aggregation decreased linearly with increasing garlic extract concentrations.
• Higher garlic concentrations used in vitro exceeded those achievable in vivo.

Conclusions:

• Dietary supplementation with garlic extract did not significantly alter platelet aggregation or related biomarkers in healthy men.
• Pharmacological concentrations of garlic extract demonstrated in vitro anti-aggregatory effects on collagen-induced platelet aggregation.
• Gastrointestinal side effects limited the administration of higher garlic doses in vivo, suggesting a need for further research into safe and effective dosages.